Joined Q2 Solutions as the Senior Director for Vaccines in August of 2019. In this role he oversees all aspects of the immunogenicity testing of vaccine products inclusive of the full assay life cycle from R&D through clinical testing. Prior to his current position he was the Director of the Immunogenicity Testing Laboratory at the NIH/NIAID/Vaccine Research Center since 2002. In this role he oversaw the immunogenicity testing for all VRC clinical trials of vaccine and broadly neutralizing antibodies. Immediately preceding the position at the NIH, Bob spend 4 years at Merck in a role as technical support for analytical testing and release for vaccines and biologicals.